MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC)
First received: July 11, 2001
Last updated: March 14, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2008|
|Primary Completion Date:||April 2008 (Final data collection date for primary outcome measure)|
Ryan QC, Headlee D, Sparreboom A, et al.: A phase I trial of an oral histone deacetylase inhibitor, MS-275, in advanced solid tumor and lymphoma patients. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-802, 2003.